Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 18Carcinoma, Hepatocellular 8Liver Neoplasms 7Colorectal Neoplasms 3Unresectable Pancreatic Cancer 2Stomach Neoplasms 2Neoplasm Metastasis 2Locally Advanced Pancreatic Cancer 2Cholangiocarcinoma 2Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pancreatic Adenocarcinoma Resectable 1Pancreatic Adenocarcinoma Locally Advanced 1Liver Metastasis Colon Cancer 1Liver Diseases 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Colorectal Liver Metastases 1Bile Duct Neoplasms 1Advanced Gastric Cancer 1

Interventions

Gemcitabine 4130-nm albumin-bound paclitaxel 3Pancreaticoduodenectomy 2Oxaliplatin 2Irinotecan 2titanium silicide 1tislelizumab 1sonidegib 1paricalcitol 1mitazalimab 1lenvatinib 1ivosidenib 1irinotecan sucrosofate 1glucoraphanin 1devimistat 1Transurethral Resection of Prostate 1Tissue Banks 1Taxes 1Specimen Handling 1Saline Solution 1S 1 (combination) 1Ropivacaine 1Robotic Surgical Procedures 1Radiomics 1Positron Emission Tomography Computed Tomography 1Parturition 1PEGPH20 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Losartan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Ductal Adenocarcinoma × Electroporation × Gastrointestinal × Clear all
NCT03257150 2022-08-11

A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer

University Health Network, Toronto

Phase NA Completed
12 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡